» Articles » PMID: 24719128

Effect of 6% Hydroxyethyl Starch 130/0.4 As a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2014 Apr 11
PMID 24719128
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Prolonged duration of cardiopulmonary bypass aggravates the degree of inflammation and coagulopathy. We investigated the influence of 6% hydroxyethyl starch (HES) 130/0.4 on coagulation and inflammation compared with albumin when used for both cardiopulmonary bypass priming and perioperative fluid therapy in patients undergoing complex valvular heart surgery.

Materials And Methods: Fifty four patients were randomly allocated into albumin-HES, albumin-nonHES, and HES-HES groups. The cardiopulmonary bypass circuit was primed with 5% albumin in the albumin-HES and albumin-nonHES group, and with HES in the HES-HES group. As perioperative fluid, only plasmalyte was used in the albumin-nonHES group whereas HES was used up to 20 mL/kg in the albumin-HES and albumin-HES group. Serial assessments of coagulation profiles using the rotational thromboelastometry and inflammatory markers (tissue necrosis factor-α, interleukin-6, and interleukin-8) were performed.

Results: Patients' characteristics and the duration of cardiopulmonary bypass (albumin-HES; 137±34 min, HES-HES; 136±47 min, albumin-nonHES; 132±39 min) were all similar among the groups. Postoperative coagulation profiles demonstrated sporadic increases in clot formation time and coagulation time, without any differences in the actual amount of perioperative bleeding and transfusion requirements among the groups. Also, inflammatory markers showed significant activation after cardiopulmonary bypass without any differences among the groups.

Conclusion: Even in the presence of prolonged duration of cardiopulmonary bypass, HES seemed to yield similar influence on the ensuing coagulopathy and inflammatory response when used for priming and perioperative fluid therapy following complex valvular heart surgery compared with conventional fluid regimen including albumin and plasmalyte.

Citing Articles

Effects of albumin and crystalloid priming strategies on red blood cell transfusions in on-pump cardiac surgery: a network meta-analysis.

Wang T, Wang J, Zhang M, Zhang H, Zhang Q, Liu G BMC Anesthesiol. 2024; 24(1):26.

PMID: 38229019 PMC: 10790517. DOI: 10.1186/s12871-024-02414-y.


Effects of crystalloid and colloid priming strategies for cardiopulmonary bypass on colloid oncotic pressure and haemostasis: a meta-analysis.

Beukers A, de Ruijter J, Loer S, Vonk A, Bulte C Interact Cardiovasc Thorac Surg. 2022; 35(3).

PMID: 35512381 PMC: 9419694. DOI: 10.1093/icvts/ivac127.


The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials.

Wei L, Li D, Sun L BMC Surg. 2021; 21(1):342.

PMID: 34511097 PMC: 8436511. DOI: 10.1186/s12893-021-01340-x.


Effects of hydroxyethyl starch 130/0.4 on the kidney tissue of rats with ureteral obstruction.

Gunes I, Sungu N, Kilicarslan A, Sivgin V, Alkan M, Kucuk A Drug Des Devel Ther. 2018; 12:3061-3070.

PMID: 30275683 PMC: 6157580. DOI: 10.2147/DDDT.S165695.


The effects of hydroxyethyl starch and gelatine on pulmonary cytokine production and oedema formation.

Krabbe J, Ruske N, Braunschweig T, Kintsler S, Spillner J, Schroder T Sci Rep. 2018; 8(1):5123.

PMID: 29572534 PMC: 5865122. DOI: 10.1038/s41598-018-23513-0.


References
1.
Westphal M, James M, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H . Hydroxyethyl starches: different products--different effects. Anesthesiology. 2009; 111(1):187-202. DOI: 10.1097/ALN.0b013e3181a7ec82. View

2.
Apostolakis E, Koletsis E, Baikoussis N, Siminelakis S, Papadopoulos G . Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg. 2010; 5:1. PMC: 2823729. DOI: 10.1186/1749-8090-5-1. View

3.
Sander M, Spies C, Martiny V, Rosenthal C, Wernecke K, von Heymann C . Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care. 2010; 14(4):R148. PMC: 2945131. DOI: 10.1186/cc9216. View

4.
Ebinger T, Ruland A, Lakner M, Schwaiger M . Validity, regulatory registration and approval of ROTEM thromboelastometry. Blood Coagul Fibrinolysis. 2010; 21(1):106-7. DOI: 10.1097/MBC.0b013e3283306e28. View

5.
Niemi T, Kuitunen A . Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand. 1998; 42(9):1104-9. DOI: 10.1111/j.1399-6576.1998.tb05385.x. View